Mémin B, Pollak P, Hommel M, Perret J
Département des Neurosciences Cliniques et Biologiques, Centre Hospitalier Régional et Universitaire de Grenoble.
Rev Neurol (Paris). 1992;148(3):212-4.
Spasticity following upper motor neuron lesion can be alleviated by few treatments such as physiotherapy, drugs and neurosurgery. However, they all have side effects, limitations or lack of selectivity. We tentatively used the paralyzing effects of botulinum toxin. Since the late 1970's the use of this toxin has increased and it has been extended to numerous muscles and diseases of various causes. In this pilot and open study we use botulinum toxin in spasticity. Eight patients (7 stroke, 1 head injury) with longstanding severe spasticity (minimum: 12 months, maximum: 15 years) were included. Spasticity greatly interfered with their activity in daily life and was resistant to oral antispastic medications. Six patients suffered from pain and 4 had cutaneous lesions especially maceration of the palm of the hand. A-botulinum toxin was injected with a 30-gauged needle. The sites chosen for injection were the following muscles: biceps brachii, brachioradialis, flexor digitorum, flexor carpi, tibialis anterior, flexor digitorum longus. Altogether 41 injections were performed. There were no side effects. Spasticity was improved in all patients. Five patients reported significant pain relief on a visual analogical scale. Most of them reported a benefit in their limb tone and referred to subjective improvement in the activity of daily life and nursing. The beneficial effects of one injection lasted more than 5 months. Seven patients received a second course of treatment. A double-blind study of botulinum toxin in spasticity is to be undertaken to assess its effectiveness and safety when prescribed in the required dose to treat this condition.
上运动神经元损伤后引起的痉挛,可通过物理治疗、药物治疗和神经外科手术等少数几种治疗方法得到缓解。然而,这些治疗方法都有副作用、局限性或缺乏选择性。我们尝试使用肉毒杆菌毒素的麻痹作用。自20世纪70年代末以来,这种毒素的使用有所增加,并已扩展到许多肌肉和各种病因引起的疾病。在这项初步的开放性研究中,我们将肉毒杆菌毒素用于治疗痉挛。纳入了8例长期严重痉挛患者(7例中风,1例头部受伤)(最短:12个月,最长:15年)。痉挛严重干扰了他们的日常生活活动,并且对口服抗痉挛药物耐药。6例患者伴有疼痛,4例有皮肤损害,尤其是手掌浸渍。用30号针头注射A型肉毒杆菌毒素。注射部位选择以下肌肉:肱二头肌、肱桡肌、指屈肌、腕屈肌、胫骨前肌、趾长屈肌。共进行了41次注射。未出现副作用。所有患者的痉挛均有改善。5例患者在视觉模拟评分上报告疼痛明显缓解。他们中的大多数人报告肢体张力有所改善,并提到日常生活活动和护理方面有主观改善。一次注射的有益效果持续超过5个月。7例患者接受了第二个疗程的治疗。将开展一项关于肉毒杆菌毒素治疗痉挛的双盲研究,以评估按所需剂量使用时治疗这种疾病的有效性和安全性。